Medicine guide

KENACORT RETARD

As listed in the register: KENACORT RETARD 40 mg/1 ml, suspension injectable

40,0 mg · suspension injectable

  • Prescription only
Made by
BRISTOL MYERS SQUIBB

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Details

Made byBRISTOL MYERS SQUIBB
Active substanceAcétonide De Triamcinolone
Strength40,0 mg
Formsuspension injectable
Routeintraarticulaire;intralésionnelle;intramusculaire
Dispensing (as stated by the register)liste I
MarketedYes, according to the register
Authorisation procedureProcédure nationale
Name in the registerKENACORT RETARD 40 mg/1 ml, suspension injectable
Packs1 flacon(s) en verre de 1 ml · 1 ampoule(s) en verre de 1 ml avec seringue(s) polypropylène avec aiguille(s) ( abrogée le 26/02/2024)
CIS65061047
CIP133400930243442
CIP133400930558751

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

  • suspension injectable2 products

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.